No Data
Even After Rising 7.4% This Past Week, Dian Diagnostics GroupLtd (SZSE:300244) Shareholders Are Still Down 55% Over the Past Three Years
Returns On Capital At Dian Diagnostics GroupLtd (SZSE:300244) Paint A Concerning Picture
dian diagnostics group (300244.SZ): The monkeypox related test kit has obtained EU CE certification
GLEH November 6th | dian diagnostics group (300244.SZ) stated on the investor interaction platform that the company's smallpox-related test kit obtained CE certification from the European Union, and the market is still being developed.
dian diagnostics group (300244.SZ): Buyback completed, cumulatively spent nearly 0.2 billion yuan to repurchase 13.88 million shares.
Delian Diagnostics Group (300244.SZ) announced that the company's share buyback period is from March 8, 2024 to October 30, 2024. The company accumulated a total of 13.88 million shares through centralized bidding trading in a buyback special securities account, accounting for 2.22% of the company's current total share capital. The highest fill price was 18.91 yuan/share, the lowest fill price was 11.64 yuan/share, and the total fill amount was 0.1995 billion yuan (excluding transaction costs). With this, the company's share buyback plan has been fully implemented.
Dian Diagnostics Group Co.,Ltd. Just Missed EPS By 44%: Here's What Analysts Think Will Happen Next
Dean Diagnosis: 2024 Q3 Report
Dian Diagnostics GroupLtd (SZSE:300244) Adds CN¥362m to Market Cap in the Past 7 Days, Though Investors From Three Years Ago Are Still Down 41%
No Data
